On November 19, 2025, Genprex, Inc. announced the addition of Gabrail Cancer Center in Canton, Ohio, as a new site for its Acclaim-1 and Acclaim-3 clinical trials on lung cancer treatments. The trials aim to expand patient access and have shown early signs of efficacy with Reqorsa® Gene Therapy.